An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
Clinical trial NCT00939783 · TERMINATED
Trial details
- NCT number
- NCT00939783
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-08-01
- Enrollment
- 649
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.